Scilex Holding Company ( SCLXW) - Key Metrics
SCLXW Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $1.11 | -$16.47 | -$0.98 | -$0.62 |
| 2026Q1 | $1.25 | -$6.28 | -$0.16 | -$0.60 |
| 2025Q4 | $0.69 | -$4.78 | -$2.58 | -$2.60 |
| 2025Q3 | $1.53 | -$37.17 | $1.19 | $1.23 |
| 2025Q2 | $1.43 | -$12.43 | $1.02 | $1.02 |
SCLXW Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | -0.46% | -0.12 |
| 2026Q1 | 0% | -0.27 |
| 2025Q4 | 0% | -0.64 |
| 2025Q3 | 0% | -0.13 |
| 2025Q2 | 0% | -0.12 |
SCLXW Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | -7.96% | 0.98% |
| 2026Q1 | -9.06% | 0% |
| 2025Q4 | -21.33% | 0% |
| 2025Q3 | 6.26% | 0% |
| 2025Q2 | 17.29% | 0% |
SCLXW
Price: $0.09
52 week price:
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - General
Market Capitalization: 33.8 million